Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.36%587.21M | 18.99%628.04M | 7.66%543.49M | 17.13%2.26B | 18.85%584.06M | 31.39%647.83M | 17.56%527.81M | 0.98%504.83M | -6.92%1.93B | -13.04%491.41M |
| Net interest income | -4.71%215.45M | 5.80%240.22M | 13.40%239.81M | 6.06%920.98M | 24.09%256.35M | 10.25%226.1M | 4.78%227.05M | -11.88%211.48M | -17.81%868.35M | -25.31%206.58M |
| -Total interest income | -7.16%742.43M | -0.46%763.51M | -1.54%749.61M | 13.20%3.1B | 4.44%777.91M | 12.06%799.72M | 16.04%767.02M | 24.31%761.34M | 31.08%2.74B | 27.21%744.83M |
| -Total interest expense | -8.13%526.98M | -3.09%523.29M | -7.29%509.79M | 16.52%2.18B | -3.10%521.57M | 12.79%573.62M | 21.53%539.97M | 47.62%549.86M | 81.22%1.87B | 74.25%538.25M |
| Non interest income | -11.85%371.76M | 28.95%387.82M | 3.52%303.68M | 26.15%1.34B | 15.05%327.71M | 46.44%421.73M | 29.49%300.75M | 12.87%293.35M | 4.37%1.06B | -1.28%284.84M |
| -Fees and commissions | -0.51%73.96M | -7.29%59.16M | -27.13%59.11M | 18.89%297.91M | 26.41%78.65M | 31.08%74.34M | -2.53%63.81M | 22.55%81.11M | 4.64%250.58M | -0.52%62.22M |
| -Including:Fees and commission income | 6.94%84.41M | 6.51%72.42M | -17.32%69.64M | 31.99%345.16M | 75.24%114.02M | 31.92%78.93M | 0.35%67.99M | 22.32%84.23M | 5.20%261.51M | 0.23%65.06M |
| -Including:Fees and commission expense | 127.52%10.45M | 217.35%13.26M | 238.21%10.53M | 332.33%47.25M | 1,141.89%35.37M | 47.21%4.59M | 82.60%4.18M | 16.45%3.11M | 19.96%10.93M | 20.27%2.85M |
| -Dividend income | -38.57%1.26M | -1.26%1.65M | 2.79%700K | 38.93%5.73M | 39.79%1.32M | -5.51%2.06M | 91.73%1.67M | 419.85%681K | -22.15%4.12M | -66.55%945K |
| -Gain loss on sale of securities | 50.73%279.73M | 55.76%296.87M | 24.31%227.98M | 18.08%780.6M | 37.48%221.02M | 4.68%185.59M | 18.13%190.59M | 13.43%183.41M | -6.32%661.09M | -21.04%160.76M |
| -Net reversal of impairment loss of financial instruments | 95.16%-1.69M | 64.88%-11.67M | 222.50%441K | -478.65%-97.44M | -361.50%-28.91M | -619.78%-34.95M | -207.54%-33.22M | 93.59%-360K | 212.91%25.73M | -427.84%-6.27M |
| -Total other operating income | -96.67%3.95M | 47.16%56.97M | 159.38%24.19M | -13.82%139.53M | -143.97%-27.18M | 160.19%118.66M | 30.79%38.71M | -62.51%9.33M | 386.75%161.89M | 162.75%61.81M |
| Credit losses provision | -747.48%-33.06M | 120.14%45.97M | 145.97%8.29M | -212.83%-53.96M | -432.42%-52.92M | -118.86%-3.9M | 10.26%20.88M | -133.55%-18.02M | -89.63%47.82M | -90.55%15.92M |
| Operating expense | -2.75%441.76M | 12.85%413.78M | -1.08%374.02M | 14.23%1.62B | 5.47%421.3M | 21.91%454.27M | 15.86%366.67M | 14.60%378.1M | 7.78%1.42B | 16.60%399.46M |
| Staff costs | -5.95%266.63M | 10.26%261.02M | -2.07%217.56M | 15.11%1.03B | 11.10%283.6M | 20.79%283.51M | 19.87%236.74M | 8.99%222.16M | 5.73%891.33M | 11.76%255.28M |
| Selling and administrative expenses | 8.36%53.56M | 13.46%47.11M | -8.25%48.77M | 6.40%193.42M | 8.80%49.32M | 18.81%49.43M | -5.31%41.52M | 4.20%53.15M | 2.00%181.79M | 374.58%45.33M |
| -Selling and marketing expense | 37.26%16.82M | -6.77%11.75M | -29.14%13.1M | 16.00%56.26M | -13.26%12.92M | 6.44%12.25M | 18.11%12.6M | 61.78%18.49M | 18.18%48.5M | 128.82%14.89M |
| -General and administrative expense | -1.16%36.75M | 22.27%35.36M | 2.90%35.66M | 2.90%137.16M | 19.59%36.41M | 23.55%37.18M | -12.84%28.92M | -12.42%34.66M | -2.84%133.29M | 899.77%30.44M |
| Depreciation and amortization | 7.27%32.92M | -6.18%31.97M | 14.63%32.67M | 15.83%126.17M | 17.58%32.91M | 18.76%30.69M | -0.23%34.08M | 36.09%28.5M | 19.30%108.93M | 9.36%27.99M |
| -Depreciation | 5.44%27.61M | -11.29%26.64M | 22.63%27.36M | 21.63%106.16M | 25.58%27.63M | 24.96%26.19M | 4.00%30.03M | 44.48%22.31M | 28.40%87.28M | 9.69%22M |
| -Amortization | 17.90%5.31M | 31.69%5.33M | -14.23%5.3M | -7.55%20.02M | -11.78%5.29M | -7.86%4.5M | -23.35%4.05M | 12.50%6.18M | -7.21%21.65M | 8.16%5.99M |
| Rent and land expenses | 44.28%16.42M | 71.30%15M | 31.20%15.37M | 70.48%41.04M | 17.44%9.18M | 55.44%11.38M | 350.80%8.76M | 67.64%11.72M | -32.33%24.08M | -46.63%7.82M |
| Insurance and claims | 21.32%6.81M | 18.69%6.89M | -16.21%6.5M | -19.37%20.74M | -74.24%1.57M | -13.55%5.61M | -14.00%5.81M | 21.32%7.76M | 2.17%25.72M | -48.11%6.09M |
| Other operating expenses | -11.17%65.43M | 30.20%51.78M | -3.03%53.16M | 14.08%212.95M | -21.49%44.71M | 29.99%73.65M | 23.16%39.77M | 34.46%54.82M | 30.73%186.67M | 8.22%56.95M |
| Income from associates and other participating interests | -74.83%2M | 112.89%24.38M | 2,113.28%22M | 50.08%54.73M | 3,718.34%34.34M | 8.51%7.95M | 0.56%11.45M | -94.69%994K | 323.48%36.47M | 94.26%-949K |
| Special income (charges) | 331.84%4.09M | -1,315.31%-12.85M | -523.82%-5.03M | -332.54%-45.14M | -812.11%-41.66M | -73.72%-1.77M | -103.63%-908K | -1,915.00%-806K | 128.22%19.41M | -127.22%-4.57M |
| Less:Restructuring and mergern&acquisition | --0 | --0 | --4.87M | 4,824.82%47.43M | 4,742.06%46.63M | --797K | --0 | --0 | 161.68%963K | --963K |
| Less:Impairment of capital assets | -98.93%9K | -98.90%12K | -92.98%59K | 10,633.33%322K | ---2.46M | 84,400.00%845K | 108,900.00%1.09M | 84,000.00%841K | -97.62%3K | --0 |
| Less:Other special charges | -2,273.45%-2.46M | 134.59%64K | ---- | 90.01%-2.67M | -141.63%-2.53M | 117.17%113K | 99.26%-185K | -6,900.00%-70K | -6,445.10%-26.7M | -104,400.00%-1.05M |
| Less:Write off | -16,550.00%-1.65M | 425,733.33%12.78M | 171.43%95K | -99.10%57K | -99.81%9K | -99.40%10K | 108.57%3K | -12.50%35K | -90.79%6.33M | 127.09%4.65M |
| Income before tax | -9.35%184.6M | 19.24%179.82M | 22.92%178.15M | 35.35%707.74M | 195.47%208.36M | 92.01%203.64M | 0.55%150.8M | -26.18%144.94M | 118.42%522.89M | 29.88%70.52M |
| Income tax | -31.49%39.61M | 12.77%36.33M | 55.67%54.06M | 64.08%198.03M | 136.46%73.27M | 931.98%57.82M | -12.32%32.22M | -26.68%34.73M | -25.20%120.7M | -17.15%30.98M |
| Net income | -0.57%144.99M | 21.00%143.49M | 12.59%124.09M | 26.73%509.7M | 241.71%135.1M | 45.16%145.82M | 4.73%118.58M | -26.02%110.21M | -66.58%402.19M | 138.68%39.54M |
| Net income continuous operations | -0.57%144.99M | 21.00%143.49M | 12.59%124.09M | 26.73%509.7M | 241.71%135.1M | 45.16%145.82M | 4.73%118.58M | -26.02%110.21M | 415.42%402.19M | 133.96%39.54M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -0.57%144.99M | 21.00%143.49M | 12.59%124.09M | 26.73%509.7M | 241.71%135.1M | 45.16%145.82M | 4.73%118.58M | -26.02%110.21M | -65.87%402.19M | 138.68%39.54M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -0.57%144.99M | 21.00%143.49M | 12.59%124.09M | 26.73%509.7M | 241.71%135.1M | 45.16%145.82M | 4.73%118.58M | -26.02%110.21M | -65.87%402.19M | 138.68%39.54M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -0.52%0.0572 | 18.91%0.0566 | 10.00%0.049 | 22.99%0.2027 | 227.32%0.0533 | 38.57%0.0575 | 0.89%0.0476 | -28.25%0.0445 | -68.01%0.1648 | 330.06%0.0163 |
| Diluted earnings per share | -0.35%0.0567 | 18.35%0.0561 | 9.42%0.0484 | 22.54%0.2008 | 225.73%0.0528 | 38.07%0.0569 | 0.47%0.0474 | -28.70%0.0442 | 380.56%0.1639 | 327.55%0.0162 |
| Dividend per share | 0 | 0 | 0 | -25.87%0.0546 | 0 | 0 | -25.87%0.0546 | 0 | -54.37%0.0736 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.